TALPHERA, INC.

TLPH

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Rock Springs Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Rock Springs CapitalNEWFeb 17, 2026

Shares: 3,589,186Value: $4.1M

# TLPH Signal Note Rock Springs Capital's $4.1M initiation (3.6M shares) in Talphera represents a healthcare specialist's bet on the company's pipeline, likely centered on its lead candidate talquetamab (GPRC5D-targeting CAR-T for multiple myeloma). Key near-term catalysts include clinical data readouts and regulatory feedback; the stock's entry point and position size suggest conviction around valuation relative to upcoming trial milestones or partnership potential.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

MLYS1 fund NBIX1 fund OLMA1 fund MIRM1 fund AMLX1 fund NAMSW1 fund OMDA1 fund REGN

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: